Profile

Dr. Lisa Butterfield, PhD

Merck Research Labs

Contact Details

Edit Your Contact Info

Bio

Lisa H. Butterfield, Ph.D. is an Adjunct Professor of Microbiology and Immunology, University California San Francisco. Her research is focused on cancer vaccines, immune profiling and cellular therapies for melanoma, hepatocellular cancer and other tumor types. Dr. Butterfield was most recently Vice President, Research and Development at the Parker Institute for Cancer Immunotherapy, where she supported cell therapy initiatives and clinical trial biospecimen and biomarker projects. Previously, she was a tenured Professor of Medicine, Surgery, Immunology and Clinical and Translational Science at the University of Pittsburgh (2003-2018) and Director of the Hillman Cancer Center Immunologic Monitoring and Cellular Products Laboratory. She has a PhD in Biology from UCLA, followed by postdoctoral fellowships in Cellular Immunology and Cancer Gene Therapy also at UCLA. She was the President of the Society of Immunotherapy of Cancer (SITC, 2017-2018) and a member of the SITC Executive Committee (2015-2020). She led the Immunology Reference Lab for the ECOG-ACRIN NCI cooperative group (2006-2018) and collaborates on biomarker studies in many clinical trials. She has published over 185 peer-reviewed manuscripts, reviews and book chapters, and mentored over 20 students and postdocs. She consults for several groups and companies, co-leads the SITC Women’s Leadership Institute and is a co-Editor of the SITC textbook “Cancer Immunotherapy: Principles and Practice” 1st and 2nd editions.

Volunteer Bio  

Society for Immunotherapy of Cancer (SITC)
[formerly: International Society for Biological Therapy of Cancer (iSBTc)]
Member, iSBTc Scientific Program Committee 2006-2008
Member, iSBTc Board of Directors 2007-2010
Steering Committee, Biomarker Taskforce 2008-2020
Strategic Plan “Goal C” Website Taskforce 2011
Society Officer: Secretary/Treasurer 2011-2014
Journal Committee 2012
Member, Council for Immunotherapy Education 2013-2021
Co-Chair, Basic/Translation Research Subcommittee 2013-2014
Society Officer: Vice-President 2014-2016
Chair, SITC Bylaws Committee 2016–2017
Society Officer: President 2016–2018
Women’s Initiatives (networking, leadership events), Chair 2017-present
Sparkathon II Judge 2018
Member, Finance Committee 2018-2020
Society Officer: Immediate Past President 2019-2020
Sparkathon 2.0 co-organizer 2020-present

Founding Section Editor, Journal for ImmunoTherapy of Cancer (JITC), Immunotherapy Biomarkers, 2012-2019
Associate Editor, Journal for ImmunoTherapy of Cancer (JITC), Immunotherapy Biomarkers, 2019-present